WebIgM antibodies to GM2, NS6S and galactocerebroside were found in 8%, 23% and 60% … Web1 aug. 2013 · Search worldwide, life-sciences literature Search. Advanced Search Coronavirus articles and preprints Search examples: "breast cancer" Smith J

Sensitivity and predictive value of anti-GM1/galactocerebroside …

Web26 apr. 2013 · GM1 antibodies are more specific for immune motor neuropathies than NS6S antibodies . About 90 % of patients with high-titer serum IgM binding to GM1 have motor neuropathies. IgM binding to NS6S is uncommon in amyotrophic lateral sclerosis but can occur in patients with sensory neuropathies who have IgM binding to MAG or TS-HDS. WebThe antibody titer is the highest in the acute phase and decreases gradually. Molecular … glenair boot

[PDF] Motor neuropathies and serum IgM binding to NS6S …

WebHigh titers ( 7000) of serum NS6S or GM1antibody in motor neuropathyincreased sensitivity from 43%, based on GM1 antibody positivity alone, to 64% when either antibody was detected. Whereas 536 Dimachkie et al none of the ALS or CIDP patients had an abnormal titer, 21% of 56 patients with sensory neuropathy had highly elevated NS6S antibody titers. WebHigh-titer IgM binding to NS6S and GM1 each occurred in 43 %, and to 1 of the 2 in 64 %, of motor neuropathy patients. Motor neuropathy syndromes were present in 25 of 27 patients with high titer serum IgM binding to GM1 in the unselected serums. IgM anti-GM1 or NS6S antibody related motor neuropathy syndromes usually have asymmetric. Web25 jun. 2010 · IgM anti-GM1 or NS6S antibody related motor neuropathy syndromes usually have asymmetric, predominantly distal, upper extremity weakness. Conclusions IgM binding to NS6S disaccharide is associated with motor neuropathy syndromes and occurs with similar frequency to IgM binding to GM1. body inflation huge